CQV stands for Commissioning, Qualification and Validation — the structured process that confirms facilities, systems, and equipment in regulated environments are ready to operate exactly as designed, before they go live. For life sciences manufacturers, this isn’t a single hand-off inspection; it’s a documented, risk-based pathway that reduces failure risk and builds the evidence base regulators expect to see. Done well, CQV turns a chaotic start-up into a predictable, audit-ready launch.
What Does CQV Actually Cover?
CQV brings together 3 connected disciplines that bridge the gap between finished construction and validated operation.
- Commissioning (C): verifying that systems and equipment are installed, connected, and functioning as engineered, before formal qualification begins
- Qualification (Q): documented evidence that installed systems and equipment are suitable for their intended use (covering installation, operational, and performance qualification)
- Validation (V): confirmation that a process consistently delivers the intended, repeatable results under real production conditions
A pharmaceutical CQV engineer typically owns this entire chain, making sure technical, quality, and documentation workstreams move in sync rather than as isolated checkpoints.
When Is CQV Required?
CQV applies wherever equipment and process reliability directly affect product quality, patient safety, or compliance with GMP standards. Across the EU and other regulated markets, this typically includes:
- new production lines and manufacturing suites;
- clean utilities (purified water, clean steam, compressed gases);
- HVAC systems supporting cleanroom classification requirements;
- laboratory and analytical instrumentation;
- computerized systems and automation platforms;
- upgrades or requalification of existing installations.
The more complex the project and the higher the quality risk, the earlier CQV planning needs to start — ideally before detailed design is finalized, not after equipment arrives on-site.
How Does the CQV Process Work?
A well-run CQV project starts long before the first test script is executed on-site. Requirements, scope, roles, and documentation get defined first; only then do teams build test plans, protocols, and acceptance criteria. This sequencing is what separates a coordinated CQV programme from a series of disconnected equipment checks.
Planning CQV Before Project Start
Early planning identifies which systems and equipment fall within CQV scope, which functions are quality-critical, and what documentation each stage will require. This is also when risk assessment and design review happen — concentrating testing effort on what genuinely matters for product quality and regulatory compliance, rather than testing everything equally.
Preparing a risk-based validation plan often means consolidating requirements and technical documentation from several sources. LISC Risk Assessment can help teams turn these inputs into structured FMEA drafts for expert review, while qualified CQV professionals remain responsible for evaluating risks and approving the final assessment.
Commissioning: Verifying Installation and Function
Commissioning confirms that equipment, installations, and interconnections match the approved design and that the system is safe to bring online. This stage includes installation reviews, Factory Acceptance Testing (FAT) at the vendor’s site, and — once equipment reaches the facility — functional testing, communication checks, alarm verification, and confirmation of readiness for formal qualification.
Qualification and Validation
- Qualification confirms that equipment and systems are correctly installed, operate as intended, and hold their required performance parameters over time.
- Validation then demonstrates that the full process, in real production use, delivers consistent, GxP-compliant results batch after batch. This is the stage where earlier documentation stops being paperwork and starts functioning as proof — for auditors, for regulators, and for a calmer start-up.
Editor’s note:
One pattern we see repeatedly in life sciences CQV is that teams treat documentation as a final deliverable rather than a live planning tool. Our pro tip is to draft your qualification protocols and acceptance criteria before equipment lands on-site, not after. It shifts CQV from reactive firefighting to controlled execution, and it’s the single change that shortens timelines most consistently.
What Commonly Delays CQV Projects?
| Common cause | Impact on the project |
| CQV started too late in the project timeline | Rushed test planning, compressed schedules |
| Incomplete or unclear design documentation | Rework, repeated testing cycles |
| No clear ownership between engineering, automation, quality, and vendors | Miscommunication, conflicting acceptance criteria |
| Scope, not risk-ranked upfront | Over-testing low-risk systems, under-testing critical ones |
Most schedule slippage traces back to one of these root causes — and nearly all of them are preventable with earlier, clearer planning.
Optimize Your CQV Programme with eLife Sciences
Complex, multi-system projects benefit from a partner who combines regulatory fluency with hands-on technical delivery. eLife Sciences provides end-to-end CQV services that bring production assets into compliant, audit-ready operation — covering everything from equipment qualification to broader validation processes across pharmaceutical and biotech facilities.
Don’t let documentation gaps or resourcing shortfalls delay your production start-up. Contact eLife Sciences to scope a full CQV outsourcing programme for your project, or to commission validation of critical computerized systems. Visit eLife Sciences to book a project review — we’ll assess your start-up timeline and provide the engineering support needed for a clean, on-schedule release to operation.
FAQs
How long does a full CQV project take for a new pharmaceutical manufacturing facility in the EU?
A full CQV process for a new EU pharmaceutical facility typically takes 6 to 18 months, depending on the site’s complexity. Starting CQV planning during the design phase can reduce timelines by up to 30%. Under EU GMP Annex 15, document approval cycles often dictate the critical path, making early risk assessments essential for keeping the schedule on track.
What is the difference between FAT, SAT and commissioning testing in CQV?
Factory Acceptance Testing (FAT) occurs at the vendor’s site to verify that equipment works before shipping. Site Acceptance Testing (SAT) happens after delivery to ensure no damage occurred during transport. Commissioning is the broader phase that integrates the equipment into the facility’s utilities, ensuring that the entire setup operates safely before formal qualification begins.
See also: Factory and Site Acceptance Tests
What is the typical team structure for a CQV project in pharmaceutical manufacturing?
A standard CQV team operates cross-functionally under a CQV Manager. It includes:
- validation engineers (handling IQ/OQ/PQ),
- automation engineers (for computerized systems),
- quality assurance (QA) who approve GMP-critical documents,
- client system owners.
Integrating the execution team early with QA ensures faster protocol approvals and prevents compliance bottlenecks.
How often must qualified systems be requalified after initial CQV completion?
Requalification isn’t strictly calendar-based, i.e., it follows a lifecycle approach. EU GMP guidelines require periodic reviews (typically annually) to assess if systems remain validated. Full requalification is mandatory after major modifications, critical component failures, or process changes. Otherwise, routine change control data serves as continuous proof of qualification.
